GB464396A - Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof - Google Patents
Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereofInfo
- Publication number
- GB464396A GB464396A GB2509235A GB2509235A GB464396A GB 464396 A GB464396 A GB 464396A GB 2509235 A GB2509235 A GB 2509235A GB 2509235 A GB2509235 A GB 2509235A GB 464396 A GB464396 A GB 464396A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxidized
- brominated
- hydroxy
- debrominated
- androstendiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
17-Hydroxy-3-keto compounds of the cyclopentanopolyhydrophenanthrene series are prepared by subjecting saturated or unsaturated 3 : 17-dihydroxy compounds of the androstane series to the action of agents capable of transforming a secondary alcohol group into a keto group. As starting materials there are used both saturated and unsaturated compounds of the androstane series, and particularly those compounds which possess a hydrocarbon radical on position 17, such as alkyl-androstandiols and androstendiols-3-17. The oxidation may be performed directly on the free diols, especially when the carbon atom 17 is substituted by a hydrocarbon radical, or the 17-hydroxy group may be protected by convertion into a group which on hydrolysis can be re-converted into a hydroxy group such as an ether, ester or halogen group. In the case of unsaturated starting materials it is preferred to protect the nuclear double bond by the addition of halogen or halogen hydride. The 17-hydroxy-3-keto compounds may be isolated from the reaction mixture by the usual methods of fractional crystallization, distillation or sublimation. Use may also be made of keto reagents and acylating agents capable of yielding difficultly soluble esters. Saponines such as digitonine are particularly useful for separation of nonreacted diol compounds. If desired, the 17-derivatives of the 17-hydroxy-3-keto compounds prepared according to the invention may be converted into the free hydroxy compounds or alternatively if the free hydroxy body has been produced it may be subsequently esterified, etherified or halogenated. In examples: (1) a glacial acetic acid solution of androstendiolmonoacetate-17 is brominated, oxidized with chromium trioxide, and debrominated with sodium iodide to yield an ester which on saponification gives a hydroxy-ketone identical with the natural material extracted from the testicles of bulls; (2) androstendiol-monoacetate-17 brominated and oxidized as in example (1) is debrominated by zinc dust to give on saponification the same keto-alcohol. Reaction of this keto-alcohol with benzoyl chloride produces the 17-benzoic acid ester which is of particular physiological value; (3) 17-methyl-androstandiol-3-17 is oxidized in glacial acetic acid solution with chromium trioxide at room temperature for 12 hours, to give 17-methyl-androstanol-17-one-3; (4) 17-methyl androstendiol-3-17 is brominated and then oxidized as in example 3. After debromination with zinc dust, a hydroxy ketone is obtained; (5) 3-hydroxy-17-chlorandrostene is brominated, oxidized, and debrominated as in example (4) to give 17-chlorandrostenone - 3; (6) androstendiol - 3 - 17 is brominated, oxidized and debrominated as in example (4). The product is then treated with digitonine and the digitonide of the dehydroandrosternone formed in the oxidation is obtained. This is removed and the residue treated with phthalic acid anhydride to isolate androstenol-17-one-3 (testosterone); (7) isoandrostandiol-mono-acetate-17 obtained from iso-androstandiol-diacetate by partial hydrolysis, is oxidized with chromium trioxide and the androstanol-17-one-3 isolated by its semicarbazide; (8) iso-androstandiol-monoacetate-17-is treated as in example (7) except that use is not made of semicarbazone; (9) iso androstandiol-monobenzoate-17 is treated as in example (8); (10) 17-ethyl-androstendiol-3 : 17 is brominated, oxidized, and debrominated as described in example (4) to give D 5 : 6-17-ethyl-androstenol-17-one-3; (11) D 5 : 6-17-ethyl-androstendiol-3 : 17 is brominated, oxidized and debrominated as described in example (4) to give D 4 : 5-17-ethyl-androstenol-17-one-3; (12) 17-methyl-androstandiol-3 : 17-monoacetate-17 is oxidized with chromium trioxide to 17-methyl-androstanol - 17 - one - 3; (13) androstendiol-monobenzoate-17 is brominated, oxidized and debrominated as described in example (4) to give androstenol-17-one-3-benzoate-17, which on hydrolysis with dilute methyl alcoholic potash gives testosterone; (14) the 17-triphenylmethyl-ether of androstendiol-3-17 is brominated in pyridine solution and chromium trioxide in a small amount of water added. The reaction proceeds at room temperature for 2 days when it is debrominated with zinc dust to give androstenol-17-one-3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2509235A GB464396A (en) | 1935-09-09 | 1935-09-09 | Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2509235A GB464396A (en) | 1935-09-09 | 1935-09-09 | Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB464396A true GB464396A (en) | 1937-04-09 |
Family
ID=10222075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2509235A Expired GB464396A (en) | 1935-09-09 | 1935-09-09 | Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB464396A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2742485A (en) * | 1954-01-15 | 1956-04-17 | Francesco Vismara Societa Per | Method for the preparation of testosterone and its esters |
-
1935
- 1935-09-09 GB GB2509235A patent/GB464396A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2742485A (en) * | 1954-01-15 | 1956-04-17 | Francesco Vismara Societa Per | Method for the preparation of testosterone and its esters |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2789989A (en) | Preparation of 21-halo steroids | |
US2752366A (en) | Carbonyloxysteroids | |
US2184299A (en) | Keto cyclopentano dimethyl polyhydro phenanthroles and a method of producing the same | |
US2774776A (en) | Dihalosteroids | |
US2352568A (en) | Compounds of the saturated and unsaturated cyclopentanopolyhydrophenanthrene-series and derivatives thereof, and process of preparing same | |
US3210406A (en) | A-norandrostenes and preparation thereof | |
GB464396A (en) | Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof | |
US2783254A (en) | Process for the manufacture of 17alpha-hydroxycorticosterone and intermediates obtained thereby | |
US2562030A (en) | Production of 17-hydroxy 20-keto steroid compounds | |
US2541074A (en) | Preparation of derivatives of 3(alpha)-hydroxycholanic acid | |
US2875201A (en) | Dehydrotigogenone intermediates | |
US3096350A (en) | 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof | |
US3154569A (en) | 19-nitrilosteroids and process for producing 19-norsteroids | |
US2232735A (en) | Saturated degradation products of sterols and a method of producing the same | |
US3231568A (en) | Processes and intermediates for preparing 16alpha-methyl corticoids | |
US2686780A (en) | Hydrolysis of 3, 20-diacyloxy-9 (11), 17 (20)-dioxido-5, 7-pregnadiene adducts | |
US2226627A (en) | Sterols of the male sex hormone type | |
US2964544A (en) | 15-hydroxy steroids of the pregnane series and process for the preparation thereof | |
US2771476A (en) | 11alpha-acyloxy-17alpha-halo-4-pregnene-3, 20-dione and process | |
US2231017A (en) | Allo-pregnane compounds and method of obtaining the same | |
US2175220A (en) | Androstendione and a method of producing the same | |
US2201121A (en) | Unsaturated derivatives of compounds of the cyclopentano polyhydro phenanthrene series and a process of producing the same | |
US2160719A (en) | Pregnanolones and methods for producing the same from pregnandiols | |
US2780621A (en) | Side chain degradation of 11-keto steroids | |
US3629302A (en) | 6-chloro-20-substituted-pregnanes |